Literature DB >> 6779377

Nonenzymatic browning in vivo: possible process for aging of long-lived proteins.

V M Monnier, A Cerami.   

Abstract

The incubation of lens proteins with reducing sugars leads to the formation of fluorescent yellow pigments and cross-like similar to those reported in aging and cataractous human lenses. Called nonenzymatic browning or the Maillard reaction, this aging process also occurs in stored foods. Reducing sugars condense with the free amino group of proteins, then rearrange and dehydrate to form unsaturated pigments and cross-linked products. Although most proteins in living systems turn over with sufficient rapidity to avoid nonenzymatic browning, some, such as lens crystallins and skin collagen, are exceptionally long-lived and may be vulnerable.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6779377     DOI: 10.1126/science.6779377

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  140 in total

Review 1.  [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].

Authors:  P P Nawroth; A Bierhaus; G E Vogel; M A Hofmann; M Zumbach; P Wahl; R Ziegler
Journal:  Med Klin (Munich)       Date:  1999-01-15

Review 2.  Advanced glycation: an important pathological event in diabetic and age related ocular disease.

Authors:  A W Stitt
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

3.  Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.

Authors:  Ricardo Gomes; Marta Sousa Silva; Alexandre Quintas; Carlos Cordeiro; António Freire; Paulino Pereira; Américo Martins; Estela Monteiro; Eduardo Barroso; Ana Ponces Freire
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

4.  Pharmacological prevention of cardiovascular aging--targeting the Maillard reaction.

Authors:  Doron Aronson
Journal:  Br J Pharmacol       Date:  2004-07-05       Impact factor: 8.739

Review 5.  Targeting advanced glycation with pharmaceutical agents: where are we now?

Authors:  Danielle J Borg; Josephine M Forbes
Journal:  Glycoconj J       Date:  2016-07-09       Impact factor: 2.916

6.  Elevated glucose 6-phosphate levels are associated with plasmid mutations in vivo.

Authors:  A T Lee; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Advanced glycation end product deposits in climatic droplet keratopathy.

Authors:  Y Kaji; R Nagai; S Amano; Y Takazawa; M Fukayama; T Oshika
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

8.  Hyperglycemia and arterial stiffness: the Atherosclerosis Risk in the Communities study.

Authors:  Jonathan Rubin; Vijay Nambi; Lloyd E Chambless; Michael W Steffes; Stephen P Juraschek; Josef Coresh; A Richey Sharrett; Elizabeth Selvin
Journal:  Atherosclerosis       Date:  2012-09-13       Impact factor: 5.162

9.  Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior.

Authors:  Brooke N Mason; Alina Starchenko; Rebecca M Williams; Lawrence J Bonassar; Cynthia A Reinhart-King
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

10.  Non-enzymatic glycation of epidermal proteins of the stratum corneum in diabetic patients.

Authors:  I Márová; J Záhejský; H Sehnalová
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.